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GABAergic transmission in the amygdala modulates the expression of anxiety. Understanding the interplay between
GABAergic transmission and excitatory circuits in the amygdala is, therefore, critical for understanding the neurobiological
basis of anxiety. Here, we used a multi-disciplinary approach to demonstrate that GluR5-containing kainate receptors regulate
local inhibitory circuits, modulate the excitatory transmission from the basolateral amygdala to the central amygdala, and
control behavioral anxiety. Genetic deletion of GluR5 or local injection of a GluR5 antagonist into the basolateral amygdala
increases anxiety-like behavior. Activation of GluR5 selectively depolarized inhibitory neurons, thereby increasing GABA
release and contributing to tonic GABA current in the basolateral amygdala. The enhanced GABAergic transmission leads to
reduced excitatory inputs in the central amygdala. Our results suggest that GluR5 is a key regulator of inhibitory circuits in the
amygdala and highlight the potential use of GluR5-specific drugs in the treatment of pathological anxiety.
Citation: Wu L-J, Ko SW, Toyoda H, Zhao M-G, Xu H, et al (2007) Increased Anxiety-Like Behavior and Enhanced Synaptic Efficacy in the Amygdala of
GluR5 Knockout Mice. PLoS ONE 2(1): e167. doi:10.1371/journal.pone.0000167
INTRODUCTION
Anxiety is thought to be a way of controlling an animal’s response to
threatening or potentially threatening stimuli, whereas excessive
levels of anxiety, or pathological anxiety, cause distress and suffering
[1,2]. The amygdala is a key circuit for processing neuronal inputs
from other parts of the brain, initiating output signals to responding
nuclei and generating various physiological responses, including
behavioral, autonomic, and hormonal responses related to anxiety
[3,4]. In both humans and animals, activation of the amygdala
elicitsanxietywhereaslesionoftheamygdalaimpairstheperception
of fear [5]. Anatomically, projecting pathways from the thalamus
and cerebral cortex terminate at the lateral amygdala and baso-
lateral amygdala (BLA). The pyramidal cells, which are primarily
glutamatergic neurons, then relay information to the central
amygdala (CeM) [6]. Local interneurons that contain GABA are
criticalinprocessing incominginformationintheBLA[7].Efferents
from the CeM then go to the periaqueductal gray, brainstem, and
hypothalamus and induce anxiety-related behavioral, autonomic
and hormonal responses [6,7].
c-Aminobutyric acid (GABA) is the primary inhibitory neuro-
transmitter in the adult mammalian brain, including the amygdala
[7]. GABAA receptors, a family of ligand-gated chloride ion
channels, mediate the effects of GABA in anxiety-related
behaviors [8–10]. Deficiencies in GABAA receptors have been
implicated in anxiety-like behavior in mice [11]. GABAA receptors
are the prime target for benzodiazepines, such as diazepam, that
alleviate anxiety in patients [12]. GABA release is important in
maintaining inhibitory tone, which also plays a role in anxiety.
For example, neuroimaging studies have demonstrated a clear
reduction of GABA levels in the occipital cortex of patients with
panic disorders [13]. Additionally, glutamate decarboxylase 65
knockout mice displayed increased anxiety-like behavior and
reduced GABA levels [14].
Inhibitory influence onto excitatory pyramidal cells, including
neurosteroid sensitive tonic inhibition, is involved in anxiety
[15,16]. A balance between excitatory and inhibitory transmission
is critical for normal brain function. Hyperexcitation due to
enhanced excitatory transmission or reduced inhibitory trans-
mission can promote anxiety-like behavior [7]. In order to
maintain such a fine balance, glutamate influences inhibitory
transmission through receptors expressed at presynaptic terminals
[17] aswellasonthepostsynapticmembranesofinhibitorysynapses
[18]. Kainate (KA) receptors, a member of the ionotropic glutamate
receptor family, have been intensely investigated in the hippocam-
pus, cortex and spinal cord [19,20]. The KA receptor family is
composed of five different subunits, namely GluR5, GluR6, GluR7,
KA1 and KA2, which can form a variety of homomeric and
heteromeric receptors [21]. KA receptors are widely distributed in
the peripheral and central nervous systems and, in particular, the
GluR5 subunit is highly expressed in dorsal root ganglion neurons,
piriform and cingulate cortices, hippocampal interneurons, as well
as in the BLA [22–24]. Recently, it was shown that GluR5 regulates
GABAergic transmission in the BLA [25]. Moreover, GluR5 also
partly mediates synaptic responses, as well as some forms of synaptic
plasticity, in the BLA [22,26]. What is currently unknown, however,
is the functional role of GluR5 in network excitability of the
amygdaloid circuitry and behavioral anxiety.
Here we provide the first evidence implicating GluR5 in
the expression of anxiety-like behavior. We show that GluR5
knockout (GluR5
2/2) mice exhibit a significant increase in
anxious behavior and that local antagonism of GluR5 in the
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GluR5
2/2 mice. We further show that GluR5 regulates
GABAergic transmission, neuronal excitability and output to the
CeM. Our results suggest that the impairment in GABAergic
transmission found in GluR5
2/2 mice affects information in-
tegration in the amygdala. This impairment may underlie the
increased expression of anxiety in GluR5
2/2 mice.
RESULTS
GluR5
2/2 Mice Exhibit Increased Anxiety-like
Behavior
To determine if GluR5 plays a role in the expression of anxiety
GluR5
2/2 (n=17) and wild-type littermate (n=10) mice were
tested on the elevated plus maze (EPM), a widely used model for
anxiety-like behavior. We found that GluR5
2/2 mice spent
significantly less time in the open arms of the EPM, as compared
to wild-type animals (P,0.05, Figure 1A). There was also
a statistically significant decrease in the number of total arm
entries (open + closed) between genotypes (P,0.05, Figure 1B).
This decrease was due to a significant reduction in open arm
entries (P,0.05) since there was no difference in the total number
of closed arm entries (P=0.24, Figure 1C). The decrease in open
arm exploration suggests that GluR5
2/2 mice have increased
anxious behavior in the EPM (Figure 1A and D).
In order to confirm that GluR5
2/2 mice exhibit enhanced
anxiety levels, we conducted a second behavioral test for anxiety,
the light/dark exploration test. Our results showed that GluR5
2/2
mice (n=8) spent significantly less time exploring the light half of
the chamber when compared to wild-type mice (n=6, P,0.05,
Figure 1E). To test for changes in mobility, motor coordination was
measured on a RotaRod and locomotor activity was recorded in an
open field. We found no significant differences between wild-type
and GluR5
2/2 mice in RotaRod performance (wild-type, n=6;
GluR5
2/2, n=10, P=0.85) or in the total distance traveled within
the open field for 30 mins (wild-type, n=7; GluR5
2/2,n = 8 ,
P=0.22) (Figure 1F). Taken together, these results provide strong
evidence for an increase in anxiety-like behavior in GluR5
2/2 mice.
Activation of GluR5 Receptors Decreases Anxiety in
Wild-type Mice
Since the deletion of GluR5 resulted in an increase in anxious
behavior, we next wanted to determine if activation of GluR5
would have the opposite effect on anxiety. The selective GluR5
agonist, ATPA, was administered via intraperitoneal injection to
wild-type mice 30 minutes before testing in the EPM. There was
a significant effect of ATPA on open arm exploration in the EPM
(P,0.05, Figure 1G). Animals treated with 5 mg/kg (n=5,
P,0.05) or 10.0 mg/kg (n=10, P,0.01) ATPA spent significantly
more time in the open arms compared to mice receiving saline
(n=9). ATPA did not affect overall exploratory activity since there
was no difference in the number of total arm entries across
treatment groups (P=0.68, Figure 1H). Taken together, our
results show that the deletion of GluR5 increases anxious behavior
in the EPM (Figure 1A) while activation of GluR5 by ATPA
decreases anxiety (Figure 1G).
Increased Anxious Behavior by Local Inhibition of
GluR5 in the BLA
Since the amygdala is an essential component of the circuitry
underlying anxious behavior, we decided to focus on the role of
GluR5 receptors in the amygdala, with particular emphasis on the
BLA. The selective GluR5 antagonist LY382884 was locally
injected into the BLA of wild-type mice and performance on the
EPM was evaluated. Mice injected with LY382882 (4 mg/ml,
n=7) spent significantly less time exploring the open arms of the
EPM compared to mice receiving the vehicle (n=8, P,0.05,
Figure 2A). There was not a significant difference in total arm
entries between treatment groups (P.0.05, Figure 2B) suggesting
that intra-amygdalar injection of LY382884 did not affect overall
exploratory activity. This result suggests that the anxiety
phenotype of GluR5
2/2 mice can be mimicked by the local
antagonism of GluR5 in the BLA.
Activation of GluR5 Depolarized Interneurons but
Hyperpolarized Pyramidal Neurons in the BLA
What is the possible mechanism for the contribution of KA GluR5
receptors to behavioral anxiety? Electrophysiological recordings in
Figure 1. Anxiety-like behavior in GluR5
2/2 mice. (A) GluR5
2/2 mice
(n=17) spent significantly less time in the open arms of the EPM
compared to wild-type mice (n=10). (B) The total number of arm
entries (open+closed) was decreased in GluR5
2/2 mice but there was
no difference in closed arm entries (C) between genotypes. (D) From
left to right: Diagram of the EPM, filled boxes=closed arms, open
boxes=open arms; representative traces showing the movement of
wild-type and GluR5
2/2 mice in the EPM for 5 mins. (E) GluR5
2/2 mice
(n=8) spent significantly less time in the light half of the chamber
compared to wild-type mice (n=6). (F) No significant difference was
detected in the distance traveled in the open field. * P,0.05. (G) While
open arm exploration was not affected by 1 mg/kg ATPA (n=5),
5.0 mg/kg (n=7) and 10.0 mg/kg (n=10) ATPA significantly increased
the time spent in the open arms compared to mice receiving saline
(n=9). (H) There was no difference in the number of total arm entries
across treatment groups.
doi:10.1371/journal.pone.0000167.g001
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Previous studies of KA receptors in the amygdala were mostly
performed in rats [22,27] only few studies were performed in adult
mice. We first determined that there were no obvious differences
in the anatomical features and neuronal density of the amygdala
between wild-type and GluR5
2/2 mice (wild-type, 1064 6 49
cells/mm
2; GluR5
2/2, 1041650 cells/mm
2; P=0.28) (Figure 3
A–C). Next, we used the whole-cell patch clamp recording
technique to measure GluR5 KA receptor-mediated currents in
pyramidal and interneurons in the BLA. Interneurons and
pyramidal neurons were identified by their different firing patterns
and morphology [28] (Figure 3F and G; Table 1). Puff-applied
ATPA (3 mM), the selective GluR5 agonist, induced inward
currents in interneurons but small or undetectable currents in
pyramidal neurons (Figure 3D and E). Significant differences were
found in the ATPA-induced current densities when comparing
interneurons and pyramidal neurons (interneuron: 2.060.3 pA/
pF, n=5; pyramidal neurons: 0.1760.03 pA/pF, n=6; P,0.01)
(Figure 3E). In the presence of GluR5 antagonist, LY293558
(30 mM), ATPA did not induce inward current in either
interneurons (n=7) or pyramidal neurons (n=7). Consistently,
no ATPA-induced current was observed in both types of neurons
in GluR5
2/2 mice (interneurons, n=8; pyramidal neurons,
n=6). These results indicate that ATPA selectively activated
interneuronal GluR5-containing KA receptors in the BLA.
To examine the effects of ATPA on neuronal excitability and
spike responses, current clamp recordings were performed. We
found that ATPA produced opposite effects on interneurons and
pyramidal cells. For interneurons, ATPA (3 mM) produced
profound depolarization (6.761.1 mV) and increased firing rate
(from 1.060.5 to 5.661.1 Hz; n=6, P,0.01); while ATPA
hyperpolarized the membrane (25.260.9 mV, n=5) and reduced
firing rate of pyramidal cells (from 0.7960.24 to 0.0660.04 Hz;
n=5, P,0.05) (Figure 3F–I). Pharmacological antagonism or
genetic deletion of GluR5 blocked ATPA effect in either
interneurons (LY293558, from 0.9560.49 to 0.9460.53 Hz,
n=5, P=0.90; GluR5
2/2, from 1.160.3 to 1.260.4 Hz, n=6,
P=0.86) or pyramidal neurons (LY293558, from 0.8860.16 to
0.9060.16 Hz, n=7, P=0.77; GluR5
2/2, from 1.060.2 to
1.060.3 Hz, n=5, P=0.99). Considering less GluR5 currents
were found in pyramidal cells, one explanation of the effects of
ATPA on pyramidal cells is through GABA released from
interneurons. We thus repeated these experiments in the presence
of the GABAA receptor antagonist, picrotoxin (100 mM). Indeed,
the effect of ATPA on pyramidal neurons was completely blocked
(Figure 3 H and I).
Activation of GluR5 Enhances Spontaneous
GABAergic, but not Glutamatergic
Neurotransmission, in the Basolateral Amygdala
As ATPA induced firing of interneurons, we speculated that
activation of GluR5 would affect GABA release in the BLA. To
test this idea, we studied the effect of ATPA on GABAergic
transmission. At a holding potential of 10 mV and in the presence
of AP-5 (50 mM) and GYKI53655 (100 mM), a selective AMPA
antagonist, spontaneous inhibitory postsynaptic currents (sIPSCs)
were pharmacologically isolated in putative pyramidal neurons in
BLA slices from adult mice. Upon bath application of ATPA
(3 mM), the frequency of sIPSCs was significantly increased to
281.3648.4% of control (from 6.160.7 Hz to 17.162.0 Hz,
n=7, P,0.01) (Figure 4A and B). The mean amplitude of sIPSCs
also significantly increased (325.4685.1%, n=7, P,0.01)
(Figure 4A and C). This facilitation was reversible after the
washout of ATPA. Moreover, the effect of ATPA was concentra-
tion-dependent, with no significant effect for 0.03 mM, a moderate
but significant effect for 0.3 mM and a robust increase by 3 mM
ATPA applied to the recording bath (Figure 4D). The facilitatory
effect of ATPA (3 mM) was completely abolished in the presence of
selective GluR5 antagonist, LY293558 (30 mM, n=4), or in the
GluR5
2/2 mice (n=4) (Figure 4E).
We next tested if glutamatergic neurotransmission in the BLA
was affected by ATPA application. At a holding potential of
270 mV and in the presence of PTX (100 mM), spontaneous
excitatory postsynaptic currents (sEPSCs) were pharmacologically
isolated. We found that bath application of ATPA (3 mM) had no
significant effect on either the frequency or amplitude of sEPSCs
in BLA pyramidal neurons (n=5, Figure 4F and G).
Increase of GABA Release by ATPA is Action
Potential Dependent
Previous studies conducted in the hippocampus and cortex have
demonstrated that KA depolarizes GABAergic interneurons via
activation of somatodendritic KA receptors [29–32] while work in
the rat spinal dorsal horn [33–35] and BLA [25] suggests that the
effect of KA and ATPA are mediated by the presynaptic location
of KA receptors. To investigate whether somatodendritic or
presynaptic KA receptors are involved in regulating GABA release
in the BLA of adult mice, we conducted experiments where
tetrodotoxin (TTX, 1 mM) was applied to the recording bath. We
found that the facilitatory effect of ATPA on sIPSCs was
completely reversed by blockade of sodium channels with TTX
(Figure 4H and I, n=5). This finding suggests that the effect of
ATPA is dependent on action potential discharge. To further
confirm these results, we studied the effects of ATPA on the
frequency and amplitude of miniature inhibitory postsynaptic
currents (mIPSCs) in the presence of TTX. Three concentrations
of ATPA (0.03, 0.3 and 3 mM) were tested and none of them had
a significant effect on either the frequency or amplitude of mIPSCs
(Figure 4J and K). Taken together, these results demonstrate that
effects of ATPA were not due to an enhancement of presynaptic
Figure 2. Pharmacological inhibition of GluR5 receptors in the
amygdala affected behavioral anxiety. (A) Mice injected with
LY382884 (n=7, 4 mg/ml) spent significantly less time in the open arms
of the EPM compared to vehicle injected mice (n=8). (B) There was no
difference in the number of total arm entries between groups. (C)
Cannula tip placement in mice injected with Vehicle (blue circles) or
LY382884 (red squares) in the BLA. (D) Representative coronal section
showing the BLA injection site (scale bar 0.6 mm). * P,0.05.
doi:10.1371/journal.pone.0000167.g002
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organization of a parasagittal hemisection through a mouse brain depicting the approximate anatomical location where immunocytochemistry was
conducted. (B and C) Nissl-stained coronal section through the BLA of representative wild-type (B) and GluR5
2/2 (C) mice. No obvious anatomical
differences between these two strains were detected. (D and E) ATPA (3 mM)-induced current in interneurons (n=5) is significantly larger than that
observed in pyramidal neurons (n=6). (F) Interneurons were identified by their morphology and firing properties. Lucifer yellow (0.1%) was loaded
through the patch pipette and confocal images were obtained after recording. A representative interneuron is shown in the inset (scale bar, 20 mM).
When injected with current steps that ranged from 2100 pA to 100 pA within 400 ms, interneurons showed fast spiking properties (top trace). In the
same neuron, bath application of ATPA (3 mM) induced neuronal depolarization and firing of the interneuron (lower trace). Resting membrane
potential for this neuron is 252.3 mV and holding current is 18.5 pA. (G) Pyramidal neurons showed different firing properties from those observed in
interneurons after current injection (top trace; representative shown in the inset, scale bar, 20 mM). In the same neuron, bath-application of ATPA
(3 mM) induced hyperpolarization and reduced the neuronal firing (lower trace). Resting membrane potential for this neuron was 266.6 mV and the
holding current was 66.9 pA. (H) Pooled data showed that ATPA (3 mM) increased firing rate of interneurons (n=6) while decreased that of pyramidal
neurons (n=5). Bath application of picrotoxin (100 mM) completely blocked the effect of ATPA in pyramidal neurons but not in interneurons. (I) Bath
application of picrotoxin (100 mM) completely abolished the hyperpolarization in pyramidal neurons (n=5) but not depolarization in interneurons
(n=5) induced by ATPA (3 mM). * P,0.05, **P,0.01.
doi:10.1371/journal.pone.0000167.g003
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rather associated with triggering action-potentials in interneurons.
Endogenous Activation of GluR5 Enhanced
GABAergic Transmission and Tonic GABA Current in
the BLA
To further explore whether there is endogenous activation of
GluR5 in the BLA, we studied sIPSCs and mIPSCs after
pharmacological blockade or genetic deletion of GluR5. We
found that bath-applied LY293558 (30 mM) significantly reduced
the sIPSC frequency in BLA pyramidal neurons of wild-type mice
(control, 6.360.6 Hz; in LY293558, 5.060.4 Hz n=6, P,0.05,
Figure 5A–C). However, we found no effect of LY293558
on mIPSC frequency (control, 2.560.5 Hz; in LY293558,
2.260.4 Hz, n=6; P.0.05). Next, we compared sIPSCs in
wild-type and GluR5
2/2 mice. A significant difference in sIPSCs
frequency was detected between wild-type and GluR5
2/2 animals
(wild-type, 6.460.5 Hz, n=12; GluR5
2/2, 4.760.4 Hz, n=11;
P,0.05) (Figure 5C). In GluR5
2/2 mice, LY293558 has no more
effect on sIPSCs (Figure 5C). Surprisingly, we found that the
frequency of mIPSCs in the BLA of GluR5
2/2 mice was
significantly decreased when compared to that of wild-type mice
(wild-type, 1.960.3 Hz, n=15; GluR5
2/2, 1.160.3 Hz, n=13;
P,0.05). These results suggest that endogenous activation of
GluR5 would facilitate GABAergic transmission.
Presynaptic GABA release participates in the generation of
tonic GABA current, which is important for the neuronal
excitability [36,37]. Tonic GABA currents in the BLA neurons
were revealed after the application of a selective competitive
GABAA receptor antagonist, bicuculline (10 mM) in wild-type
mice (Figure 5D and E, 218.662.9 pA, n=12). In GluR5
2/2
mice, tonic GABA currents were significantly decreased (Figure 5D
and E, 28.561.6 pA, n=11, P,0.05). Tonic GABA currents
were also significantly reduced in the presence of LY293558 in
wild-type and GluR5
2/2 mice (wild-type, 7.261.6 pA, n=9,
P,0.01; GluR5
2/2, 7.162.4 pA, n=8, P,0.05, Figure 5E). Both
vesicular and non-vesicular releases of GABA contribute to tonic
receptor activation [38], we want to know whether GluR5
modulates different sources of GABA for tonic GABA current.
Bath application of TTX (1 mM) revealed the tonic inward current
in the wild-type mice (8.560.9 pA, n=8) and subsequent
application of bicuculline (10 mM) caused increase of tonic GABA
current (6.560.9 pA, n=8, Figure 5F). In GluR5
2/2 mice, we
found that TTX-sensitive tonic current is significantly decreased
(2.960.8 pA, n=8, P,0.05, Figure 5F). The further application of
bicuculline induced the similar inward current in wild-type and
GluR5
2/2 mice (5.260.9 pA, n=8, P=0.43, Figure 5F). These
results suggest that endogenous interneuronal GluR5 activation
modulates action potential-dependent tonic GABA current.
Activation of GluR5 in the Basolateral Amygdala
Inhibits Excitatory Projections to the Central
Amygdala
The inhibitory drive from local inhibitory neurons targeting to
pyramidal neurons is critical for regulating neuronal excitability
and subsequent information processing in the brain [39,40]. Since
there are synaptic connections from the BLA to the CeM [41,42],
we wanted to determine if GluR5 modulation on GABAergic
transmission affects synaptic projection within this pathway. To
delineate the role of GluR5 in the transmission of information
from the BLA to the CeM, we locally puff-applied ATPA to the
BLA and measured spontaneous excitatory post-synaptic currents
(sEPSCs) in CeM neurons (Figure 6A). Most CeM neurons showed
delayed firing properties (Figure 6A). Application of ATPA in the
BLA significantly reduced the frequency of sEPSCs in CeM
neurons (63.3615.2%, n=11, P,0.05, Figure 6B).
Next, we measured the effect of GluR5 activation on evoked
EPSCs (eEPSCs) in CeM neurons obtained by stimulating the
BLA. These responses were polysynaptic, showing both inward
glutamatergic and outward GABAergic currents at a holding
potential of 245 mV (Figure 5A). Application of CNQX (20 mM)
blocked both inward and outward responses, confirming that the
outward GABAergic current was due to feed forward inhibition
from the intercalated cell masses, an inhibitory interface between
BLA and CeM [42,43]. At holding potential of 270 mV, which is
near the reversal potential for GABAergic currents, only inward
currents were observed, which could be completely abolished by
CNQX (Figure 6A). After obtaining a stable eEPSC, ATPA
(3 mM) was locally applied to the BLA. Puff-applied ATPA into
the BLA significantly and reversibly decreased eEPSCs in the
CeM (75.766.3%, n=7, P,0.01, Figure 6C and D). These
findings indicate that the activation of GluR5 in the BLA exerts an
inhibitory effect on excitatory output to the CeM in the amygdala.
Role of GluR5 in Excitatory Synaptic Transmission
and Plasticity from the Basolateral Amygdala to
Central Amygdala
To further address the role of GluR5 in the regulation of
intra-amygdaloid connections, we compared baseline synaptic
transmission in BLA to CeM synapses between wild-type and
GluR5
2/2 mice. At a holding potential of 270 mV, evoked
Table 1. Basic electrophysiological properties of BLA neurons.
..................................................................................................................................................
Pyramidal neuron Interneuron Significant Difference
Number of neurons tested 31 25
Resting membrane potential, mV 264.461.0 255.361.7 P,0.01
Membrane capacitance, pF 87.363.7 36.961.9 P,0.01
Input resistance, MV 77.564.6 355.1644.2 P,0.01
Rheobase current, pA 94.366.8 27.564.0 P,0.01
Action potential threshold, mV 237.361.1 239.261.0 P=0.34
Action potential amplitude, mV 98.861.8 89.061.7 P,0.01
Action potential half-width, ms 1.5560.04 1.0360.06 P,0.01
Values are Mean6SEM. Significant differences were obtained by the two-tailed, unpaired student t-test.
doi:10.1371/journal.pone.0000167.t001
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First, we tested the input-output relationship of AMPA receptor-
mediated eEPSCs in CeM neurons. In the presence of AP5
(50 mM), we found a significant difference in the amplitude of
eEPSCs between wild-type and GluR5
2/2 mice at lower
intensities of stimulation (4V, 3.161.3 pA, n=8 vs 11.862.2
pA, n=7, P,0.05; 5V, 13.464.6 pA, n=8 vs 35.268.4 pA n=7,
P,0.05, Figure 7A and B). However, when the stimulation
intensity was increased, no difference was found in the eEPSCs
between control and knockout mice (Figure 7A and B). To further
study the selective role of GluR5 in the BLA, we locally puffed
selective GluR5 antagonist, LY382884 (10 mM) into the BLA and
then studied the input-output curve in wild-type mice. Consis-
tently, we found that application of LY382884 in the BLA
increased eEPSCs in CeM at lower stimulation intensity
(Figure 7C, n=8).
In addition to basal synaptic transmission, we also examined
whether the GluR5 deletion affected long-term synaptic potenti-
ation in the CeM. It has been reported that LTP in BLA to CeM
synapses could be induced by high frequency stimulation [44]. We
Figure 4. Activation of GluR5 by ATPA reversibly increased sIPSCs but not sEPScs or mIPSCs. (A) A representative example of ATPA (3 mM)
modulation of sIPSCs in a BLA pyramidal neuron. The top trace represents sIPSCs recorded before, during and after ATPA application. The bottom 3
traces are presented at an expanded scale. (B and C) Time course for the ATPA-induced enhancement of sIPSC frequency and amplitude in the
neuron shown in (A). Note the effect of ATPA is reversible. (D) The facilitatory effect of ATPA on sIPSC frequency is concentration dependent
(0.03 mM, n=6; 0.3 mM, n=5; 3 mM, n=7). (E) The effect of ATPA (3 mM) could be blocked by LY293558 (30 mM, n=4) or in GluR5
2/2 mice (n=4),
suggesting that the ATPA’s action is mediated by GluR5. *Indicates a significant difference from control without treatment of ATPA. (F and G) ATPA
(3 mM) had little effect on either frequency or amplitude of sEPSCs (n=5). (H and I) A representative trace (F) and time course of drug effect (G)
showing that TTX (1 mM) fully reversed the enhancement of sIPSC induced by ATPA treatment (3 mM). Similar results were obtained from an
additional 4 neurons. (J and K) In the presence of TTX (1 mM), ATPA did not affect either amplitude or frequency of mIPSCs. Three concentrations of
ATPA were used and none had significant effects on sIPSC frequency or amplitude (0.1 mM, n=7; 0.3 mM, n=6; and 3 mM, n=7).
doi:10.1371/journal.pone.0000167.g004
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previously used in the anterior cingulate cortex and lateral
amygdala, to induce LTP in CeM neurons [45,46].?A significant,
long-lasting synaptic potentiation was observed in slices of wild-
type mice after induction (150.265.9% of baseline, n=8 slices/6
mice, P,0.05 compared with baseline responses before induction,
Figure 7D). This protocol also induced LTP in GluR5
2/2 mice
(157.468.0%, n=8 slices/5 mice; P,0.05 compared with
baseline responses, Figure 7E) and the magnitude of synaptic
potentiation in GluR5
2/2 mice was similar to that of wild-type
mice (P,0.05). These results indicate that long-term plasticity was
normal in BLA to CeM synapses in GluR5
2/2 mice.
DISCUSSION
The present work provides strong evidence for a role of GluR5-
containing KA receptors in anxiety. Our results show that
activation of GluR5 potently regulates GABAergic transmission
and network excitability in the amygdala. Based on these findings
we propose that impaired GABAergic transmission, due to the lack
of GluR5, may underlie the development of anxiety-like behavior
in GluR5
2/2 mice. Manipulations directed at GluR5-containing
receptors may aid in the development of selective and effective
anxiolytic drugs in the future.
Despite an increased understanding of the physiological actions
of GluR5 at the cellular level, less is known about its role in
behavioral functions [19]. Recent studies showed that GluR5 is
involved in chronic pain [47,48] and epileptogenesis [27,49,50].
However, a role for GluR5 in anxiety, an emotional behavior
related to amygdala function, has not been reported. In the
present study, our results clearly demonstrate a role for GluR5 in
anxiety. GluR5
2/2 mice showed an increase in anxiety-like
behavior in both the elevated plus maze and light/dark test. These
changes are unlikely due to a reduction in general locomotion
since performances in the open field and on the RotaRod were
similar between knockout and wild-type mice. As further
demonstrations of the role of GluR5 in anxiety, we found that
wild-type mice displayed less anxious behavior when receiving
ATPA whereas they showed more anxiety by local GluR5
Figure 5. Endogenous activation of GluR5 increases GABA release and tonic GABA current in the BLA. (A) Representative traces of LY293558
(30 mM) modulation of sIPSCs in a BLA pyramidal neuron. (B) Cumulative probability plot showing that LY293558 application decreased sIPSC
frequency in the neuron showed in (A). (C) Pooled data showing that LY293558 reduced the frequency of sIPSCs in wild-type mice. GluR5
2/2 showed
the decreased sIPSC frequency compared that in wild-type mice. * P,0.05 compare with GluR5
2/2 mice, # P,0.05 compared with control without
LY293558 application in wild-type mice. (D) Perfusion of bicuculline (10 mM) induced a baseline shift (the tonic GABA current) in BLA neurons from
both wild-type and GluR5
2/2 mice. (E) Tonic GABAergic current was reduced in BLA pyramidal neurons of GluR5
2/2 mice (wild-type, n=12; GluR5
2/
2, n=11). In the presence of LY293558 (30 mM), tonic GABA current was also significantly reduced (n=9). * P,0.05 compare with GluR5
2/2 mice, #
P,0.01 compared with control without LY293558 application in wild-type mice. (F) Bath application of TTX (1 mM) induced tonic GABAergic current
in wild-type mice (n=8). In GluR5
2/2 mice (n=8), the TTX-induced tonic current is smaller than that in wild-type mice. Further application of
bicuculline caused the similar tonic current in both mice. * P,0.05.
doi:10.1371/journal.pone.0000167.g005
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microinjection of ATPA into the amygdala due to the occurrence
of side effects. These novel findings raise the possibility that GluR5
in the BLA may underlie the behavioral expression of anxiety.
Although our microinjection results clearly showed that GluR5 in
the BLA is involved in the expression of anxiety, we cannot
exclude the possibility that other brain regions may also contribute
to the increased anxiety phenotype in GluR5
2/2 mice. In
addition, the evidence that EPM involves the amygdaloid complex
is weak, despite that recent studies do show that amydala is
important for the anxious behaviors. For example, intra-amygdala
injection of different metabotropic glutamate receptor agonists
decreased anxious behavior in the EPM [51] and anxiogenic drugs
lead to an increase in immediate early gene expression within the
amygdale [52].
Previous reports show that GluR5 is expressed in the BLA
where it participates in synaptic transmission, modulation and
plasticity in young rats [22,25]. The present study provides direct
evidence for the important role of GluR5-containg KA receptors
in inhibitory interneurons. Furthermore, the current density of
GluR5 activation was larger in interneurons as compared to
pyramidal neurons. In agreement with these results we found that
ATPA induced interneuronal depolarization and spiking behavior,
in contrast to pyramidal neurons where ATPA triggers hyperpo-
larization. We also showed that GABAA receptor antagonist
picrotoxin blocked hyperpolarization in pyramidal neurons, but
not the depolarization in interneurons. Taken together, these
results lead us to conclude that: (1) GluR5 is predominant and
highly functional in interneurons; activation of GluR5 in this cell
type triggers neuronal firing and subsequent release of GABA; (2)
Significantly less GluR5 activity (or expression) is found in
pyramidal neurons as compared to levels in interneurons; (3)
GluR5 activation in pyramidal neurons may be counteracted by
the activation of GABAA receptors, resulting from the bulk release
of GABA from interneurons which were fired by GluR5
activation. Therefore, activation of GluR5 reduces the excitability
of pyramidal cells in the BLA.
Our result showed that GluR5 is selectively acting on inhibitory
but not excitatory synaptic transmission in the BLA. Bidirectional
modulation of GABA release by presynaptic GluR5 (measured by
both mIPSCs and eIPSCs) was reported in the young rat BLA, in
which different types of GluR5-containing KA receptors, with
different agonist affinities, were proposed to mediate the biphasic
effect [25]. Our results, using adult mice, suggest a different
mechanism. We first showed that, ATPA did not affect the
frequency or amplitude of mIPSCs. Three different concentrations
Figure 6. Activation of GluR5 in the BLA affected the output to the CeM in the amygdala. (A) Diagram showing the placement of the stimulating
electrode (Sti) and drug puff-application pipette (Puff) in the BLA as well as recording electrode (Rec) in the CeM (left). A typical late-firing neuron
showed the delayed firing properties in respond to current steps that from 250 pA to 75 pA within 400 ms (right). Resting membrane potential for
this neuron is 263.3 mV. Scale bar, 15 mV and 80 ms. Lower traces showing evoked responses in a CeM neuron by electric stimulation in the BLA. At
holding potential of 245 mV, biphasic responses were observed and CNQX application could block both of them. At holding potential of 270 mV,
only inward current was observed. (B) Typical recording and cumulative probability plot showing that ATPA (3 mM) application in the BLA decreased
sEPSCs in a CeM late-firing neuron. Inset: Relative frequency (freq.) during ATPA application was significantly decreased (n=6). (C) Typical traces
showing that after puff application of ATPA (3 mM) in the BLA, eEPSCs recorded in a CeM neuron were decreased. (D) Individual experiments and
statistical results showing that ATPA reduced eEPSC amplitude (n=7, each neuron represented by a separate symbol). * P,0.05, **P,0.01.
doi:10.1371/journal.pone.0000167.g006
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mIPSCs, although highly visible impacts on sIPSCs were observed.
Our results suggest that GluR5 may be located on somatoden-
drites rather than on presynaptic terminals. At present, no clear
explanations exist for these differences. However, it may be
possible that the age (young vs. adult animals) and the species used
(mouse vs. rat) may contribute to these differences.
Two lines of evidence in the present study directly showed that
GluR5 is endogenously activated. First, the frequency of sIPSCs
and mIPSCs was significantly lower in GluR5
2/2 mice compared
to wild-type mice. Second, the selective GluR5 antagonist,
LY293558 reduced sIPSC frequency. Therefore, we believe that
GluR5 is tonically activated by endogenous glutamate in the
extracellular fluid. In addition to synaptic currents (phase current),
GABAA receptors also mediate a persistent tonic current, which
reflects the activation of high-affinity GABAA receptors by low
ambient GABA concentration [38]. It has been reported that tonic
GABA current is mainly mediated by a5-containing GABAA
receptors in hippocampal CA1 neurons [53] and by d-containing
GABAA receptors in granule cells of hippocampal dentate gyrus or
cerebellum [15]. However, no report is available concerning the
tonic inhibitory currents in amygdala neurons. This is the first
study to report that GABAA receptor mediated tonic inhibition
exists in pyramidal neurons in the amygdala of adult mice.
Furthermore, we showed that this inhibition is under the tonic
regulation of GluR5-containing KA receptors on BLA interneur-
ons. Genetic deletion of GluR5 or pharmacological blockade of
GluR5 could significantly reduce the tonic GABA current. Our
results showed that TTX itself induced tonic GABA current in
WT mice but significant smaller tonic current in GluR5
2/2 mice,
while subsequent application of bicuculline caused similar tonic
current in both. These results suggest that the source of GABA for
tonic GABA current partially involves the action potential-
dependent GABA release, which may spill over to activate the
extrasyanptic GABAA receptors.
Tonic inhibition is thought to contribute to the control of
neuronal excitability by reducing neuronal input-output functions
[38]. Consistently, we found a reduced input-output relationship
of synaptic transmission from the BLA to the CeM in GluR5
2/2
mice. The increased synaptic efficacy observed at low, but not
high, intensities of stimulation suggests that GluR5 finely
modulates synaptic transmission by tonic inhibition. Local
application of selective GluR5 antagonist, LY382884 in the BLA
mimicked the phenoma found in GluR5
2/2 mice, suggesting that
endogenous activation of GluR5 in the BLA may modulate the
functional output to the CeM. Local application of ATPA (3 mM)
in the BLA still decreased strong stimulation-induced eEPSCs
recorded from the CeM (control, 81.2612.1 pA; ATPA, 44.066.6
pA, n=6, P,0.05). These results suggest that exogenous
activation of GluR5 in the BLA has robust inhibitory effect while
endogenous activation of GluR5 exert defined modulatory effect
on projection from BLA to CeM. However, we cannot exclude the
possibility that the evoked responses may partially contain that
from the passing fibers.
In summary, we report here that GluR5
2/2 mice showed
increased anxiety-like behavior and the mechanisms for GluR5’s
role in anxiety may involve impaired GABA release, tonic
inhibition, network excitability and the excitatory output from
BLA to CeM. However, it should be noted that the anxiety
phenotype detailed here was obtained in a global knockout for
GluR5, which lacks regional specificity. It is therefore not possible
to discount potential roles for GluR5 in other brain regions related
to emotional behavior. Our results using local administration of
a selective GluR5 antagonist to show the same increase in anxious
behavior partially addresses this concern. However, further
studies, using temporally and spatially selective gene targeting
Figure 7. GluR5
2/2 mice exhibit less synaptic efficacy from the BLA to CeM, but no change long-term potentiation. (A) Typical samples showing
eEPSCs recorded in CeM neurons by stimulation in the BLA in wild-type and GluR5
2/2 mice. The stimulation intensities range from 4 V to 10 V. (B)
Input-output curve of eEPSCs indicated that at lower stimulation intensity, eEPSCs in wild-type mice were significantly smaller than those in GluR5
2/2
mice. No difference was found at a higher stimulation intensity (wild-type, n=8; GluR5
2/2, n=7). (C) Local application of LY382884 (10 mM) has
similar effect on input-output curve of eEPSC to that in GluR5
2/2 mice, increasing weak stimulation-induced eEPSCs (n=8). (D and E) LTP could be
induced in CeM neurons by theta burst stimulation in the BLA from wild-type mice (n=8) or GluR5
2/2 mice (n=8). There was no significant
difference in potentiation between groups. The dashed line indicates the mean basal synaptic responses and the arrow shows the time point of LTP
induction. *P,0.05.
doi:10.1371/journal.pone.0000167.g007
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GluR5 in anxiety in a region specific manner void of possible
developmental compensations. Despite this limitation, our results
clearly show that GluR5-containing KA receptors are involved in
regulating anxious behavior and may serve as a target for novel
anxiolytics in the future.
MATERIALS AND METHODS
Animals
Adult C57BL/6 mice were purchased from Charles River (6–
10 weeks old). GluR5
2/2 mice were obtained as gifts from Dr.
Stephen Heinemann (Salk Institute, San Diego, CA) [54,55].
GluR5
2/2 mice were maintained on a mixed 129Sv x C57BL/6
background and wild-type littermates were used as controls. As it
was impossible visually to distinguish mutant mice from wild-type
mice, all experiments were performed in a blind fashion. All mice
were maintained on a 12 h light/dark cycle with food and water
provided ad libitum. All protocols used were approved by The
Animal Care and use Committee at the University of Toronto and
conform to NIH guidelines.
Whole-cell Patch Clamp Recordings
Adult male mice (6–10 weeks old) were anesthetized with 1–2%
halothane and decapitated. Coronal slices of the amygdala
(300 mm) were prepared using routine methods used in our lab
[48]. Slices were then transferred to a room temperature
submerged recovery chamber with oxygenated (95% O2 and 5%
CO2) solution containing (in mM): NaCl, 124; NaHCO3, 25; KCl,
2.5; KH2PO4, 1; CaCl2, 2; MgSO4, 2; glucose, 10. After a one-
hour recovery period, slices were placed in a recording chamber
on the stage of an Axioskop 2FS microscope (Zeiss, Thornwood,
NY) equipped with infrared DIC optics for patch clamp
recordings. Postsynaptic currents were recorded with an Axon
200B amplifier (Molecular Devices, Union City, CA). Stimulations
were delivered using a bipolar tungsten stimulating electrode
locally placed in the BLA. Electric square-wave voltage pulse
(200 ms, 4–14 V) was generated using a Grass S88 stimulator
(Grass instrument Co., Quincy, MA) attached to a Grass SIU5D
isolator unit. Recording electrodes (2–5 MV) contained an
internal solution composed of (in mM): Cs-gluconate, 120; NaCl,
5; MgCl2 1; EGTA, 0.5; Mg-ATP, 2; Na3GTP, 0.1; HEPES, 10;
pH 7.2; 280–300 mOsmol. Cs-gluconate was replaced by
equimolar K-gluconate when we performed current clamp
recordings. Unless stated otherwise, the membrane potential was
held at 270 mV throughout all experiments. Theta burst
stimulation was used as LTP induction paradigm. This protocol
involved five trains of burst with four pulses at 100 Hz, at 200 ms
interval; repeated four times at intervals of 10 s. When recording
GABAA receptor-mediated currents, a holding potential of 10 mV
was used, as indicated in the body of the text.
Immunohistochemistry
Animals (n=6) were overdosed with sodium pentobarbital and
perfused transcardially with 20 ml of 0.1M phosphate buffered
saline (PBS; pH=7.4) and 4% paraformaldehyde in PBS. Brains
were then dissected out, cryoprotected in 30% sucrose, included in
embedding medium (Tissue-Tek; Sakura Finetek, Torrance, CA),
fast-frozen in dry-ice, cut coronally on a cryostat (20 mm), thaw-
mounted on glass slides and allowed to dry overnight. Sections
were re-hydrated by incubation in alcohol solutions of decreasing
concentrations (100, 95, 70, 50%; 2 mins each) and placed in
distilled water for 5 mins. Next, sections were placed in a 0.5%
Cresyl violet solution for 5 mins, dehydrated in a series of alcohols,
defatted in xylenes and coverslipped. The neuronal density was
estimated using the Nissl-stained sections. Three areas around
0.01 mm
2 in the BLA were randomly picked and number of
neurons was counted in each area. The neuronal density in the
slice was obtained by averaging the density in three areas.
Pharmacological Drugs
AP-5 and GYKI53655 were used to selectively block NMDA
receptors and AMPA receptors, respectively. ATPA was used to
selectively activate GluR5-containing KA receptors. All chemicals
and drugs were obtained from Sigma (St. Louis, MO), except for
ATPA, which was purchased from Tocris (Ellisville, MO).
GYKI53655 was a kind gift from Drs. John F. MacDonald
(University of Toronto) and Geoffrey T. Swanson (University of
Texas). Most drugs were applied to the perfusion solution using
methodologies previously described by our group. Local puff
application of drug was described previously [56].
Elevated Plus Maze
The elevated plus maze (Med Associates, St. Albans, Vermont)
consisted of two open arms and two closed arms situated opposite
to each other. For each test, individual animals were placed in the
center square and allowed to move freely for five minutes. The
number of entries and time spent in each arm was recorded.
ATPA (1.0, 5.0 or 10.0 mg/kg) (i.p., 0.9% saline, Sigma Aldrich,
St Louis, MO) was injected 30 min before testing. Saline injections
were used are controls. A video camera tracking system
(Ethovision, Noldus VA) was used to generate the traces shown
in Figure 1D.
Open Field Activity Monitor
To record horizontal locomotor activity we used the Activity
Monitor system from Med Associates (43.2643.2630.5 cm;
MED-associates, St. Albans, VT). Briefly, this system uses paired
sets of photo beams to detect movement in the open field and
movement is recorded as beam breaks. The open field is placed
inside an isolation chamber with dim illumination and a fan. Each
subject was placed in the center of the open field and activity was
measured for 30 minutes.
Light/Dark Test
The testing apparatus (Med Associates, St Albans, VT) consisted
of a rectangular Plexiglas box (4468.5625 cm) equally divided
into a light compartment connected by a door (17 cm in height) to
a dark compartment. Each mouse was placed in the light box and
was allowed 10 sec to explore before the door to the dark box was
opened. The time spent in both compartments was recorded for
10 min.
RotaRod
To test for motor coordination we used the RotaRod from Med-
Associates (St, Albans, Vermont). One hour before testing, animals
were trained on the RotaRod set at 16 rpm until they could stay
on for 30 s. For testing, the RotaRod was set to accelerate from
4 rpm to 40 rpm over the course of 5 min, the latency to complete
two consecutive rolls or to drop off the rod (performance) was
recorded.
Amygdala Cannulation and Microinjection
Under ketamine and xylazine anesthesia, 24-gauge guide cannulas
were implanted bilaterally into the BLA (21.4 mm anterior to
Bregma, 63.3 mm lateral from the midline, 5.0 mm beneath the
GluR5 in the Anxiety
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after cannula implantation. All procedures were performed in
accordance with the requirements of the Animal Studies
Committee at the University of Toronto. The 30-gauge injection
cannula was 0.1 mm lower than the guide. For intra-amygdala
infusion, 0.5 ml LY382884 (4 mg/ml, 5% DMSO) or vehicle was
delivered bilaterally. Twenty minutes later, mice were tested in the
EPM.
Data Analysis
Results were expressed as mean 6 standard error of the mean (S.
E. M.). Statistical comparisons were performed with the Student
T-test or one-way analysis of variance (ANOVA). Analysis of
miniature or spontaneous postsynaptic currents was performed
with cumulative probability plots and was compared using the
Kolmogorov-Smirnov (K-S) test for significant differences. In all
cases, P,0.05 was considered statistically significant.
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